Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 358Precursor Cell Lymphoblastic Leukemia-Lymphoma 164Leukemia 160Lymphoma 109Myelodysplastic Syndromes 74Lymphoma, Non-Hodgkin 66Lymphoma, Large B-Cell, Diffuse 61Lymphoma, Mantle-Cell 59Burkitt Lymphoma 58Recurrence 56Congenital Abnormalities 44Leukemia, Monocytic, Acute 39Lymphoma, Follicular 37Hodgkin Disease 35Leukemia, Myelomonocytic, Acute 34Leukemia, Erythroblastic, Acute 34Leukemia, Megakaryoblastic, Acute 32Blast Crisis 29Lymphoma, Large-Cell, Immunoblastic 27Leukemia, Myelomonocytic, Chronic 26Leukemia, Lymphocytic, Chronic, B-Cell 26Leukemia, Biphenotypic, Acute 26Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, B-Cell, Marginal Zone 19Anemia, Refractory, with Excess of Blasts 19Myeloproliferative Disorders 17Lymphoma, B-Cell 17Leukemia, Myeloid, Accelerated Phase 16Neoplasm, Residual 15

Interventions

Cyclophosphamide 7fludarabine phosphate 6venetoclax 5tagraxofusp 5Whole-Body Irradiation 4Mycophenolic Acid 4Methotrexate 4fludarabine 3Thiotepa 3Dexamethasone 3Cyclosporine 3Calcium Dobesilate 3merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Vincristine 2Tacrolimus 2Specimen Handling 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Cytarabine 2Cyclosporins 2Azacitidine 2prednylidene 1lorvotuzumab mertansine 1exifone 1deltacortene 1azathiopurine 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Blastic Plasmacytoid Dendritic Cell Neoplasm × Cytarabine × Clear all
NCT04216524 2026-04-14

Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

M.D. Anderson Cancer Center

Phase 2 Recruiting
40 enrolled
Myeloid

Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT05476770 2024-12-06

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Recruiting
54 enrolled
LymphoidMyeloidOther hematologic neoplasm

Blastic Plasmacytoid Dendritic Cell Neoplasm, Hodgkin Disease, Leukemia, Biphenotypic, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡